semaglutide effetti collaterali collaterali, Prac: neuropatia ottica evento molto raro con La semaglutide potrebbe avere benefici

Many patients experience initial rapid weight loss in the first 812 weeks, then hit a plateau as their body adjusts to the appetite-suppressing effects

Like other incretin-based medications, the most common side effects were gastrointestinal: Common Side Effects Nausea: Reported in approximately 25-45% of participants depending on dose (most common during titration) Diarrhea: Approximately 20-35% of participants Vomiting: Approximately 10-20% of participants Constipation: Approximately 10-15% of participants Decreased appetite: Common and expected given the mechanism of action Less Common but Notable Effects Increased heart rate: Small elevations in resting heart rate were observed, consistent with other GLP-1 class medications Injection site reactions: Mild redness or itching at injection sites Fatigue: Reported by some participants, particularly during dose escalation Most adverse events were mild to moderate and occurred primarily during the dose escalation phase

Youre spending more time on the toilet, needing to push or strain

It depends entirely on your vial concentration

The genetic test maps 14 metabolic pathways and analyzes 150+ insights into how your body processes appetite-regulating peptides